| Field | Specification |
|---|---|
| Mfr No | |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates, cell lysates. |
| Sensitivity | |
| Species | |
| Target |
Background
Keratin, type I cytoskeletal 18 fragment (K18-Asp396)ELISA Kit (CK 18M30) is a biological molecule commonly studied in others research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
Biological context
Researchers often monitor Keratin, type I cytoskeletal 18 fragment (K18-Asp396)ELISA Kit in serum, plasma, tissue homogenates, and cell lysates. to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Keratin, type I cytoskeletal 18 fragment (K18-Asp396)ELISA Kit may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Keratin, type I cytoskeletal 18 fragment (K18-Asp396)ELISA Kit participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
CYTOKERATIN CK 18 (M30): A Novel Biomarker in Acute Liver Failure
C Malik,Hepatology research,2023
The efficacy of serum cell death biomarkers for diagnosing biliary tract cancer
Sugimoto M, et al,Scientific Reports,2018
The Utility of M30 and M65 Antigen Concentration Levels for Predicting Degree of Hepatic Injury in Patients with Chronic Hepatitis B Infection
Mustafa Çelik, et al,/,2018
Serum levels of a cell death biomarker predict the development of cirrhosis-related conditions in primary biliary cholangitis
Hayashi M.et al,Med Mol Morphol,2018
No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Barchetta I.et al,BMC Med.,2016
Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.
Qin Y. et al,PLoS One,2015